Predictive value of response to treatment of T-lymphocyte subpopulations in idiopathic pulmonary fibrosis

European Respiratory Journal

Volumn 11, Issue 3, 1998, Pages 706-711

  Fireman, E ^a,f   Vardinon, N ^a   Burke, M ^a   Spizer, S ^b   Levin, S ^c   Endler, A ^d   Stav, D ^e   Topilsky, M ^a   Mann, A ^a   Schwarz, Y ^a   Kivity, S ^a   Greif, J ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c WOLFSON MEDICAL CENTER   (Israel)

^d Tel Aviv University Sackler Faculty of Medicine   (Israel)

^e ASSAF HAROFEH MEDICAL CENTER   (Israel)

^f TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Bronchoalveolar lavage; Idiopathic pulmonary fibrosis; Monoclonal antibodies; T cell subsets

Indexed keywords

CYCLOPHOSPHAMIDE; PREDNISONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DIAGNOSTIC VALUE; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTER; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG FIBROSIS; LUNG LAVAGE; MALE; PRIORITY JOURNAL; PROGNOSIS; T LYMPHOCYTE SUBPOPULATION; TREATMENT OUTCOME;

BRONCHOALVEOLAR LAVAGE FLUID; CD4-CD8 RATIO; CELL COUNT; CELL SEPARATION; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREDNISONE; PULMONARY FIBROSIS; RESPIRATORY FUNCTION TESTS; T-LYMPHOCYTE SUBSETS; TIME FACTORS;

EID: 17444434000     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Jackson LK. Idiopathic pulmonary fibrosis. Clin Chest Med 1982; 3: 579-592.
2. Raghu G. Idiopathic pulmonary fibrosis. A rational clinical approach. Chest 1987; 92: 148-154.
3. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-590.
4. Hunninghake GW, Crystal RG. Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med 1981; 305: 429-434.
5. Izumi T, Nagai S, Fujimura N. Clinical value of the measurement of bronchoalveolar fluid subsets in interstitial lung diseases. Chest 1986; 89 (Suppl.): 136s.
6. Ginns RC, Goldenheim PD, Burton RC, et al. T-lymphocyte subsets in peripheral and lung lavage in idiopathic pulmonary fibrosis in sarcoidosis: analysis by monoclonal antibodies and flow cytometry. Immunol Immunopathol 1982; 25: 11-20.
7. Chemiac RM, Crystal RG, Kalika AR. Current concepts in idiopathic pulmonary fibrosis: a road map for the future. Am Rev Respir Dis 1991; 143: 680-683.
8. American Thoracic Society Statement. Snowbird workshop on standardization of spirometry. Am Rev Respir Dis 1979; 119: 831-838.
9. Reynolds HY, Fulmer JD, Kazmierowski JA, Roberts WC, Frank MM, Crystal RG. Analysis of cellular and protein content of bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. J Clin Invest 1977; 59: 165-175.
10. Weinberger SE, Kelman JA, Elson NA, et al. Bronchoalveolar lavage in interstitial lung disease. Ann Intern Med 1978; 89: 459-466.
11. Haslam PL, Turton CWG, Lukoskek A, et al. Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy. Thorax 1980; 35: 328-339.
12. Hannet I, Erkeller-Yuksel F, Lydyard P, Deneys V, DeBruyere M. Development and maturational changes in human blood lymphocyte populations. Immunol Today 1992; 13: 215-218.
13. Thrall RS, Barton RW. A comparison of lymphocyte populations in lung tissue and in bronchoalveolar lavage fluid of rats at various times during the development of bleomycin-induced pulmonary fibrosis. Am Rev Respir Dis 1984; 129: 279-283.
14. Cailes JB, O'Connor C, Pantelidis P, et al. Neutrophil activation in fibrosing alveolitis: a comparison of lone crytogenic fibrosing alveolitis and systemic sclerosis. Eur Respir J 1996; 9: 992-999.
15. Law KF, Jagirdar J, Weiden MD, Bodkin M, Rom WN. Tuberculosis in HIV-positive patients: cellular response and immune activation in the lung. Am J Respir Crit Care Med 1996; 153: 1377-1384.
16. Von Eiff M. Schlinggheider O, Schulze F, Zuhidorf M, Van de Loo J. Differential cell count and lymphocyte subsets in bronchoalveolar lavage during pneumonia with and without peripheral neutropenia. Lung 1995; 173: 25-33.
17. Markenschlager M, Beverley PCL. Evidence for differential expression of CD45 isoform by precursors for memory dependent and independent cytotoxic responses: human CDS memory CTLp selectively express CD45R. Int Immunol 1989; 1: 450-459.
18. Richerson HB, Coon J, Lubaroff D. Experimental hypersensitivity pneumonitis in the rat: histopathology and T-cell subset compartmentalization. Am Rev Respir Cell Mol Biol 1991; 5: 451-463.
19. Meyers CM, Kelly CJ. Effector mechanism in organ-specific autoimmunity 1. Characterization of a CD8 T-cell line that mediated murine interstitial nephritis. J Clin Invest 1991; 88: 408-416.
20. Reinherz EL, Schlossman SF. Regulation of the immune response: inducer and suppressor T lymphocyte subsets in human beings. N Engl J Med 1980; 303: 370-380.
21. Scott J. Johnston I, Britton J. What causes cryptogenic fibrosing alveolitis. A case-control study of environmental exposure to dust. Br Med J 1990; 301: 1015-1017.
22. Costabel U, Bross KJ, Reuter KH, Mathys H, Alterations in immunoregulatory T-cell subsets in cigarette smokers: a phenotypic analysis of bronchoalveolar and blood lymphocytes. Chest 1986; 90: 39-44.
23. Schwartz DA, Van Fossen DS, Davis CS, et al. Determinants of progression in idiopathic pulmonary fibrosis. Am Respir Crit Care Med 1994; 149: 444-449.
24. Agusti C, Xaubet A, Agusti AGN, Roca J, Ramirez J, Rodriguez-Roisin R. Clinical and functional assessment of patients with idiopathic pulmonary fibrosis: results of 3 year follow-up. Eur Respir J 1994; 7: 643-650.
25. Tung KT, Well AU, Rubens MB, Kirk JME, du Bois RM, Hansell DM. Accuracy of typical computed tomographic appearances of fibrosing alveolitis. Thorax 1993; 48: 334-338.
26. Line BR, Fulmer JD, Reynolds JY, et al. Gallium-67 citrate scanning in the staging of idiopathic pulmonary fibrosis: correlation with physiologic and morphologic features and bronchoalveolar lavage. Am Rev Respir Dis 1978; 118: 355-365.
27. du Bois RM. Diffuse lung disease: a view for the future. Sarcoidosis 1997; 14: 23-30.
28. Wells AU, du Bois RM. Prediction of disease progression in idiopathic pulmonary fibrosis. Eur J Respir 1994; 7: 637-639.
29. Thrall RS. Barton RW, D'Amato DA, Sulavik SB. Differential cellular analysis of bronchoalveolar lavage fluid obtained at various stages during the development of bleomycin-induced pulmonary fibrosis in rat. Am Rev Respir Dis 1982; 126: 488-492.
30. Braun RK, Sterner Kock A, Kilshaw PJ, Ferrick DA, Giri SN. Integrin alpha E beta 7 expression on BAL CD4+, CD8+ and gamma delta T-cells in the bleomycin-induced lung fibrosis in mouse. Eur Respir J 1996; 9: 673-679.